Cargando…
Real-World Outcomes for Patients Treated With Immune Checkpoint Inhibitors in the Veterans Affairs System
Increasingly broad patient groups are being treated with immune checkpoint inhibitors (ICIs) in clinical practice, but few studies have assessed their usage and outcomes in large, comprehensive real-world cohorts. We identified patients who received ICIs in the Veterans Affairs (VA) health care syst...
Autores principales: | La, Jennifer, Cheng, David, Brophy, Mary T., Do, Nhan V., Lee, Jerry S.H., Tuck, David, Fillmore, Nathanael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608595/ https://www.ncbi.nlm.nih.gov/pubmed/33074743 http://dx.doi.org/10.1200/CCI.20.00084 |
Ejemplares similares
-
Prevalence and Outcome of COVID-19 Infection in Cancer Patients: A National Veterans Affairs Study
por: Fillmore, Nathanael R, et al.
Publicado: (2020) -
Prognostic value of the veterans affairs frailty index in older patients with non‐small cell lung cancer
por: Cheng, David, et al.
Publicado: (2022) -
Factors Associated With Severe COVID-19 Among Vaccinated Adults Treated in US Veterans Affairs Hospitals
por: Vo, Austin D., et al.
Publicado: (2022) -
Sentiment analysis of medical record notes for lung cancer patients at the Department of Veterans Affairs
por: Elbers, Danne C., et al.
Publicado: (2023) -
Inadequate Sars-Cov-2 Vaccine Effectiveness in Patients with Multiple Myeloma: A Large Nationwide Veterans Affairs Study
por: Fillmore, Nathanael R, et al.
Publicado: (2021)